Insulet Corp. Reaches New 12-Month High at $37.99 (PODD)
Shares of Insulet Corp. (NASDAQ:PODD) hit a new 52-week high on Wednesday, StockRatingsNetwork reports. The company traded as high as $37.99 and last traded at $37.73, with a volume of 232,074 shares trading hands. The stock had previously closed at $37.18.
A number of research firms have recently commented on PODD. Analysts at JMP Securities downgraded shares of Insulet Corp. (NASDAQ:PODD) from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, September 20th. They now have a $33.00 price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Insulet Corp. (NASDAQ:PODD) from $29.00 to $38.00 in a research note to investors on Friday, August 9th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. Insulet Corp. has a consensus rating of “Hold” and a consensus target price of $30.77.
Insulet Corp. has a one year low of $18.50 and a one year high of $37.96. The stock’s 50-day moving average is $34.82 and its 200-day moving average is $30.58. The company’s market cap is $2.044 billion.
Insulet Corp. (NASDAQ:PODD) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.20) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.19) by $0.01. The company had revenue of $60.09 million for the quarter, compared to the consensus estimate of $60.47 million. During the same quarter last year, the company posted ($0.30) earnings per share. Insulet Corp.’s revenue was up 17.7% compared to the same quarter last year. Analysts expect that Insulet Corp. will post $-0.63 EPS for the current fiscal year.
Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (NASDAQ:PODD).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.